Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 58

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part I, Item 1
Chunk 58
---
Item 1. FINANCIAL STATEMENTS

The Cigna GroupConsolidated Statements of IncomeUnauditedUnauditedThree Months Ended June 30,Six Months Ended June 30,(In millions, except per share amounts)2025202420252024RevenuesPharmacy revenues$53,649 $45,101 $102,282 $87,137 Premiums9,156 11,454 21,892 23,057 Fees and other revenues4,137 3,647 8,032 6,973 Net investment income236 321 474 611 TOTAL REVENUES67,178 60,523 132,680 117,778 Benefits and expensesPharmacy and other service costs53,268 44,492 101,666 85,923 Medical costs and other benefit expenses7,749 9,515 18,247 18,955 Selling, general and administrative expenses3,433 3,684 7,646 7,389 Amortization of acquired intangible assets422 420 844 843 TOTAL BENEFITS AND EXPENSES64,872 58,111 128,403 113,110 Income from operations2,306 2,412 4,277 4,668 Interest expense and other(337)(375)(699)(697)Gain (loss) on sale of businesses— — 41 (19)Net investment gains (losses)52 (48)50 (1,884)Income before income taxes2,021 1,989 3,669 2,068 TOTAL INCOME TAXES389 360 628 651 Net income1,632 1,629 3,041 1,417 Less: Net income attributable to noncontrolling interests100 81 186 146 SHAREHOLDERS' NET INCOME$1,532 $1,548 $2,855 $1,271 Shareholders' net income per shareBasic$5.76 $5.51 $10.63 $4.48 Diluted$5.71 $5.45 $10.55 $4.43 

The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.

3

The Cigna GroupConsolidated Statements of Comprehensive